The Molecular Concept of Atheromatous Plaques.

Abstract:

BACKGROUND:Recently, there are scientific attempts to discover new drugs in the biotechnology industry in order to treat various diseases including atherosclerosis. OBJECTIVE:The main objective of the present review was to highlight the cellular, molecular biology and inflammatory process related to the atheromatous plaques. METHODS:A thorough literature search of Pubmed, Google and Scopus databases was done. RESULTS:Atherosclerosis is considered to be a leading cause of death throughout the world. Atherosclerosis involves oxidative damage to the cells with production of reactive oxygen species (ROS). Development of atheromatous plaques in the arterial wall is a common feature. Specific inflammatory markers pertaining to the arterial wall in atherosclerosis may be useful for both diagnosis and treatment. These include Nitric oxide (NO), cytokines, macrophage inhibiting factor (MIF), leucocytes and Pselectin. Modern therapeutic paradigms involving endothelial progenitor cells therapy, angiotensin II type-2 (AT2R) and ATP-activated purinergic receptor therapy are notable to mention. CONCLUSION:Future drugs may be designed aiming three signalling mechanisms of AT2R which are (a) activation of protein phosphatases resulting in protein dephosphorylation (b) activation of bradykinin/nitric oxide/cyclic guanosine 3',5'-monophosphate pathway by vasodilation and (c) stimulation of phospholipase A(2) and release of arachidonic acid. Drugs may also be designed to act on ATP-activated purinergic receptor channel type P2X7 molecules which acts on cardiovascular system.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Thent ZC,Chakraborty C,Mahakkanukrauh P,Nik Ritza Kosai Nik Mahmood N,Rajan R,Das S

doi

10.2174/1389450117666160502151600

subject

Has Abstract

pub_date

2017-01-01 00:00:00

pages

1250-1258

issue

11

eissn

1389-4501

issn

1873-5592

pii

CDT-EPUB-75331

journal_volume

18

pub_type

杂志文章,评审
  • Biomarkers, critical disease pathways, drug targets, and alternative medicine in male breast cancer.

    abstract::While breast cancer (BC) is commonest malignancy among female with highest death rate, male breast cancer (MBC) is very rare but exhibits highest cancer specific death in men and the incidences of MBCs are rising rapidly. Due to rarity of the disease, no detail information about biomarkers and drug targets available a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787122842

    authors: Barh D

    更新日期:2009-01-01 00:00:00

  • Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.

    abstract::Breast cancer remains the leading cause of cancer death among females worldwide. It signifies a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Current treatment modalities, including surgery, radiotherapy, and adjuvant chemotherapy or hormone therapy, have not be...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545632

    authors: Sinha D,Biswas J,Sung B,Aggarwal BB,Bishayee A

    更新日期:2012-12-01 00:00:00

  • The therapeutic value of natural agents to treat miRNA targeted breast cancer in African-American and Caucasian-American women.

    abstract::Breast cancer is the most common cancer in women in the United States, with African-American (AA) women showing significantly higher rates than Caucasian-American (CA) women do. The reason for this racial disparity remains unknown, and factors that might be responsible for the differences in incidence and mortality ha...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545461

    authors: Rahman KM,Sakr WA

    更新日期:2012-12-01 00:00:00

  • Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.

    abstract::Classical antidepressant drugs such as Selective Serotonin Reuptake Inhibitors (SSRIs) display several disadvantages, e.g., the onset of action (2 to 3 weeks) to start clinical benefits is too long, and a significant proportion of patients do not respond to this monotherapy. Several strategies have been proposed to ov...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945006775515428

    authors: Guiard BP,Lanfumey L,Gardier AM

    更新日期:2006-02-01 00:00:00

  • PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.

    abstract::PDZ domains play an essential role in a number of cellular processes by facilitating protein scaffolding and assembly of protein complexes. These domains consist of 80 to 90 amino acids and are found to recognize short C-terminal sequences of target proteins. Protein complex formation between PDZ target molecules can ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666141219120125

    authors: Holcomb J,Spellmon N,Trescott L,Sun F,Li C,Yang Z

    更新日期:2015-01-01 00:00:00

  • Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.

    abstract::Trauma-induced coagulopathy (TIC) is a recently described condition which traditionally has been diagnosed by the common coagulation tests (CCTs) such as prothrombin time/international normalized ratio (PT/INR), activated partial thromboplastin time (aPTT), platelet count, and fibrinogen levels. The varying sensitivit...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160310153211

    authors: Walsh M,Fritz S,Hake D,Son M,Greve S,Jbara M,Chitta S,Fritz B,Miller A,Bader MK,McCollester J,Binz S,Liew-Spilger A,Thomas S,Crepinsek A,Shariff F,Ploplis V,Castellino FJ

    更新日期:2016-01-01 00:00:00

  • The Role of Dietary Compounds in the Therapy of Nicotine-Induced Osteoporosis.

    abstract::Nicotine is one of the most abused substances worldwide and can cause several harmful effects on health. One of the harmful effects, which is often ignored, is osteoporosis. Smoking has been shown to cause a decrease in bone mineral density in humans. Animal studies have proven that nicotine exerts negative effects on...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450118666170925154428

    authors: Mohamed N,Muhammad N,Shuid AN,Soelaiman IN

    更新日期:2018-01-01 00:00:00

  • Mitochondrial drug targets in apicomplexan parasites.

    abstract::In evolutionary terms, mitochondria in apicomplexan parasites appear to be "relicts-in-the-making": they possess the smallest mitochondrial genomes known, encoding only three proteins, and in one genus, Cryptosporidium, the genome is eliminated altogether. Several features of mitochondrial physiology provide validated...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007779315632

    authors: Mather MW,Henry KW,Vaidya AB

    更新日期:2007-01-01 00:00:00

  • Baculovirus late and very late gene regulation.

    abstract::Baculoviruses have adapted novel tactics to transcribe their genes during the late stages of replication. These include a DNA-directed RNA polymerase which is evolutionarily divergent from cellular polymerases. The viral RNA polymerase is a multisubunit and multifunctional RNA polymerase that has the ability to recogn...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007782151324

    authors: Passarelli AL,Guarino LA

    更新日期:2007-10-01 00:00:00

  • Anti-TNF antibody therapy for inflammatory bowel disease during pregnancy: a clinical review.

    abstract::The incidence of inflammatory bowel disease (IBD; Crohn's disease, ulcerative colitis) is highest during the peak reproductive years, hence the increased concern with the safety of IBD drugs during pregnancy. Over the past 11 years, anti-TNF-alpha antibody therapy has emerged as a treatment approach for refractory IBD...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010790309885

    authors: El Mourabet M,El-Hachem S,Harrison JR,Binion DG

    更新日期:2010-02-01 00:00:00

  • microRNAs: innovative targets for cerebral ischemia and stroke.

    abstract::Stroke is one of the leading causes of death and disability worldwide. Because stroke is a multifactorial disease with a short therapeutic window many clinical stroke trials have failed and the only currently approved therapy is thrombolysis. MicroRNAs (miRNA) are endogenously expressed noncoding short single-stranded...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945013804806424

    authors: Ouyang YB,Stary CM,Yang GY,Giffard R

    更新日期:2013-01-01 00:00:00

  • Endogenous Cardioprotective Agents: Role in Pre and Postconditioning.

    abstract::Cardiovascular diseases (CVD) are the leading cause of death, chronic illness and disability in Western countries. The most common cause of CVD derives from the harmful effects of acute myocardial ischemia and subsequent reperfusion injury. Cardioprotection against acute ischemia/ reperfusion injury is made possible b...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150309115536

    authors: Penna C,Granata R,Tocchetti CG,Gallo MP,Alloatti G,Pagliaro P

    更新日期:2015-01-01 00:00:00

  • Interferon alpha for treatment of chronic myeloid leukemia.

    abstract::Treatment of chronic myeloid leukemia (CML) with interferon-alpha (IFN-α) was introduced in the early 1980s. Several clinical trials showed a survival advantage for patients treated with IFN-α compared to conventional chemotherapy. Some patients achieved longstanding complete cytogenetic remissions (i.e. >2 log tumor ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011794815301

    authors: Simonsson B,Hjorth-Hansen H,Bjerrum OW,Porkka K

    更新日期:2011-03-01 00:00:00

  • Unique structural motif supports mannosylphospho dolichol synthase: an important angiogenesis regulator.

    abstract::Mannosylphospho dolichol synthase (DPMS) catalyzes the transfer reaction GDP-mannose + Dol-P <--> Dol-P-Man + GDP, a 'key step' in the assembly of lipid-linked oligosaccharide (LLO) and a pre-requisite for asparagine-linked (N-linked) protein glycosylation. DPMS is present from a protozoan parasite to human, and its s...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/138945008783954916

    authors: Baksi K,Tavárez-Pagán JJ,Martínez JA,Banerjee DK

    更新日期:2008-04-01 00:00:00

  • Potential options to treat hypertriglyceridaemia.

    abstract::Hypertriglyceridaemia is associated with insulin resistance, hypertension, obesity and diabetes. The management of hypertriglyceridaemia and atherogenic dyslipidaemias increasingly involves the use of several drugs for different aspects of the metabolic syndrome. This review highlights the agents for treatment of bloo...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009787846380

    authors: Viljoen A,Wierzbicki AS

    更新日期:2009-04-01 00:00:00

  • ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors.

    abstract:BACKGROUND:Pediatric tumors remain the highest cause of death in developed countries. Research on novel therapeutic strategies with lesser side effects is of utmost importance. In this scenario, the role of Renin-Angiotensin System (RAS) axes, the classical one formed by angiotensinconverting enzyme (ACE), Angiotensin ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200210124217

    authors: de Paula Gonzaga ALAC,Palmeira VA,Ribeiro TFS,Costa LB,de Sá Rodrigues KE,Simões-E-Silva AC

    更新日期:2020-01-01 00:00:00

  • Pancreatic Neoplasms and Autophagy.

    abstract::Pancreatic cancer is predicted to be the second deadliest malignancy (a median survival of 4-6 months and a 5-year survival of less than 5%) in the USA by 2020. Although current medical detection technologies have dramatically improved the survival rate for patients with other gastrointestinal malignancies, the dismal...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160622220915

    authors: Barton LA,Ren J

    更新日期:2018-01-01 00:00:00

  • Virally encoded G protein-coupled receptors: targets for potentially innovative anti-viral drug development.

    abstract::Various herpes- and poxviruses contain DNA sequences encoding proteins with homology to cellular chemokine receptors, which belong to the family of G protein-coupled receptors (GPCRs). Since GPCRs play a crucial role in cellular communication and chemokine receptors play a prominent role in the immune system, the vira...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450033491000

    authors: Smit MJ,Vink C,Verzijl D,Casarosa P,Bruggeman CA,Leurs R

    更新日期:2003-07-01 00:00:00

  • Advances in Inhibitors of FXa.

    abstract::Thromboembolic diseases such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI) and ischemic strokes are mainly responsible for people's morbidity and mortality and have severely affected the people's quality of life all over the world. According to WHO statistics, an average of 17 mill...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150518095533

    authors: Guo L,Ma S

    更新日期:2015-01-01 00:00:00

  • Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction.

    abstract::It is well known that calorie restriction (CR) can retard the aging process in organisms ranging from yeast to non-human primates, and delay the onset of numerous age-related diseases including neurodegenerative disorders. Translation of the knowledge gained from CR research in animal models to disease prevention stra...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111007011281

    authors: Duan W,Ross CA

    更新日期:2010-10-01 00:00:00

  • Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models.

    abstract::Disorders of emotion regulation such as anxiety disorders and depression are common and yet debilitating. Accumulating evidence suggests involvement of serotonin (5-HT) in the regulation of emotion. Mice with targeted deletion of genes encoding mediators of the serotonergic transmission have proven to be a powerful to...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314050005

    authors: Araragi N,Lesch KP

    更新日期:2013-05-01 00:00:00

  • Regulation of thrombospondin1 by extracellular proteases.

    abstract::The contribution of proteases to developmental, physiological and pathological processes has been well accepted. Cleavage of matrix proteins is a key requirement for cell migration and remodeling of the extracellular environment. The constant process of matrix turnover is dependent on the delicate balance between degr...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008785909365

    authors: Iruela-Arispe ML

    更新日期:2008-10-01 00:00:00

  • Functional roles of synaptic and extrasynaptic NMDA receptors in physiological and pathological neuronal activities.

    abstract::The N-methyl-D-aspartate (NMDA) receptor is a major type of ionotropic glutamate receptor. Many studies have shown that NMDA receptors play a pivotal role in the central nervous system (CNS) under both physiological and pathological conditions. The functional diversity of NMDA receptors can be mainly attributed to the...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012799201630

    authors: Li ST,Ju JG

    更新日期:2012-02-01 00:00:00

  • Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

    abstract::The adenosine pathway is a powerful evolutionarily selected mechanism aimed at a fine modulation of inflammatory responses and protection of tissues from injuries. Adenosine exerts its modulatory effects via interaction with G protein-coupled receptors, designated as A(1), A(2A), A(2B) and A(3). In this regard, extrac...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012800564095

    authors: Antonioli L,Colucci R,La Motta C,Tuccori M,Awwad O,Da Settimo F,Blandizzi C,Fornai M

    更新日期:2012-06-01 00:00:00

  • Biology of Cox-2: an application in cancer therapeutics.

    abstract::Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed that Cox-2 is over-expressed in cancer and stroma cells during tumor progression, and anti-cancer chemo-radiotherapies induce expression of Co...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011795677764

    authors: Khan Z,Khan N,Tiwari RP,Sah NK,Prasad GB,Bisen PS

    更新日期:2011-06-01 00:00:00

  • PPARs: a potential target for a disease-modifying strategy in stroke.

    abstract::Stroke is one of the major causes of mortality and disability in adults in industrialized countries. Despite numerous preclinical studies and clinical trials in the field of cerebral ischemia, no pharmacological agent has been validated in the treatment of acute ischemic, except thrombolysis. Cerebral ischemia is not ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314070005

    authors: Ouk T,Potey C,Gautier S,Bastide M,Deplanque D,Staels B,Duriez P,Leys D,Bordet R

    更新日期:2013-06-01 00:00:00

  • Improving the embryo implantation via novel molecular targets.

    abstract::With the development of modern assisted reproductive technology(ART), the treatment of infertility and the pregnant outcome by ART have been significantly improved. However, implantation failure, particularly the unexplained repeated implantation failure (RIF), is still the unsolved and principal problem to affect the...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314080006

    authors: Li J,Liang X,Chen Z

    更新日期:2013-07-01 00:00:00

  • Decreasing the metastatic potential in cancers--targeting the heparan sulfate proteoglycans.

    abstract::The heterogeneity of proteoglycans (PG)s contributes to their functional diversity. Many functions depend on their ability to bind and modulate the activity of components of the extracellular matrix (ECM). The ability of PGs to interact with other molecules, such as growth factors, is largely determined by the fine st...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054863662

    authors: Fjeldstad K,Kolset SO

    更新日期:2005-09-01 00:00:00

  • Proline Oxidase (POX) as A Target for Cancer Therapy.

    abstract::Proline dehydrogenase/proline oxidase (PRODH/POX) is an enzyme catalyzing the first step of proline degradation, during which ROS and/or ATP is generated. POX is widely distributed in living organisms and is responsible for a number of regulatory processes such as redox homeostasis, osmotic adaptation, cell signaling ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011613151031150637

    authors: Kononczuk J,Czyzewska U,Moczydlowska J,Surażyński A,Palka J,Miltyk W

    更新日期:2015-01-01 00:00:00

  • Adaptors in toll-like receptor signaling and their potential as therapeutic targets.

    abstract::To initiate the innate immune response, Toll-like receptors (TLRs) associate with cytoplasmic adaptor proteins through TIR (Toll/interleukin-1 receptor) domain interactions. The four principal signaling adaptor proteins include MyD88, MAL, TRIF and TRAM, and the fifth protein SARM, involved in negative regulation of T...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012803530260

    authors: Ve T,Gay NJ,Mansell A,Kobe B,Kellie S

    更新日期:2012-10-01 00:00:00